Mdxhealth Sa Adr Stock Buy Hold or Sell Recommendation
| MDXH Stock | USD 1.88 0.17 9.94% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding MDxHealth SA ADR is 'Hold'. The recommendation algorithm takes into account all of MDxHealth's available fundamental, technical, and predictive indicators you will find on this site.
Check out MDxHealth Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as MDxHealth and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
MDxHealth |
Execute MDxHealth Buy or Sell Advice
The MDxHealth recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MDxHealth SA ADR. Macroaxis does not own or have any residual interests in MDxHealth SA ADR or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MDxHealth's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
MDxHealth Trading Alerts and Improvement Suggestions
| MDxHealth SA ADR generated a negative expected return over the last 90 days | |
| MDxHealth SA ADR may become a speculative penny stock | |
| MDxHealth SA ADR has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 70.19 M. Net Loss for the year was (43.1 M) with profit before overhead, payroll, taxes, and interest of 19.22 M. | |
| MDxHealth SA ADR currently holds about 40.02 M in cash with (21.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 12.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: AWM Investment Companys Strategic Acquisition of MDxHealth SA Shares |
MDxHealth Returns Distribution Density
The distribution of MDxHealth's historical returns is an attempt to chart the uncertainty of MDxHealth's future price movements. The chart of the probability distribution of MDxHealth daily returns describes the distribution of returns around its average expected value. We use MDxHealth SA ADR price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MDxHealth returns is essential to provide solid investment advice for MDxHealth.
| Mean Return | -0.9 | Value At Risk | -6.29 | Potential Upside | 3.50 | Standard Deviation | 3.89 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MDxHealth historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MDxHealth Stock Institutional Investors
| Shares | Rhumbline Advisers | 2024-06-30 | 72.0 |
MDxHealth Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (4.2M) | (6.1M) | 42.5M | (43.0M) | 6.9M | 7.2M | |
| Free Cash Flow | (22.4M) | (20.8M) | (23.4M) | (38.3M) | (26.5M) | (27.8M) | |
| Depreciation | 3.4M | 3.3M | 3.0M | 4.9M | 6.9M | 7.2M | |
| Other Non Cash Items | 1K | 26K | (325K) | (429K) | 16.2M | 17.0M | |
| Capital Expenditures | 73K | 537K | 896K | 4.2M | 5.0M | 5.3M | |
| Net Income | (43.2M) | (27.1M) | (26.8M) | (37.9M) | (43.1M) | (40.9M) | |
| End Period Cash Flow | 22.1M | 16.0M | 58.5M | 15.5M | 22.4M | 27.4M | |
| Change To Inventory | 615K | (1.1M) | 413K | (416K) | (452K) | (474.6K) | |
| Investments | (73K) | (537K) | (885K) | (29.2M) | (6.5M) | (6.8M) | |
| Net Borrowings | 8.7M | 1.5M | (1.1M) | 22.1M | 25.4M | 26.7M | |
| Change To Netincome | 7.1M | 3.1M | 3.1M | 6.6M | 7.6M | 4.0M |
MDxHealth Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MDxHealth or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MDxHealth's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MDxHealth stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.97 | |
β | Beta against Dow Jones | 0.68 | |
σ | Overall volatility | 3.89 | |
Ir | Information ratio | -0.26 |
MDxHealth Volatility Alert
MDxHealth SA ADR exhibits very low volatility with skewness of -2.58 and kurtosis of 11.53. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MDxHealth's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MDxHealth's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MDxHealth Fundamentals Vs Peers
Comparing MDxHealth's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MDxHealth's direct or indirect competition across all of the common fundamentals between MDxHealth and the related equities. This way, we can detect undervalued stocks with similar characteristics as MDxHealth or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MDxHealth's fundamental indicators could also be used in its relative valuation, which is a method of valuing MDxHealth by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MDxHealth to competition |
| Fundamentals | MDxHealth | Peer Average |
| Return On Equity | -2.41 | -0.31 |
| Return On Asset | -0.11 | -0.14 |
| Profit Margin | (0.50) % | (1.27) % |
| Operating Margin | (0.26) % | (5.51) % |
| Current Valuation | 90.7 M | 16.62 B |
| Shares Outstanding | 49.5 M | 571.82 M |
| Shares Owned By Insiders | 12.20 % | 10.09 % |
| Shares Owned By Institutions | 48.65 % | 39.21 % |
| Number Of Shares Shorted | 14.24 K | 4.71 M |
| Price To Book | 4.98 X | 9.51 X |
| Price To Sales | 1.00 X | 11.42 X |
| Revenue | 70.19 M | 9.43 B |
| Gross Profit | 19.22 M | 27.38 B |
| EBITDA | (30.47 M) | 3.9 B |
| Net Income | (43.1 M) | 570.98 M |
| Cash And Equivalents | 40.02 M | 2.7 B |
| Cash Per Share | 2.57 X | 5.01 X |
| Total Debt | 41.27 M | 5.32 B |
| Debt To Equity | 0.48 % | 48.70 % |
| Current Ratio | 2.38 X | 2.16 X |
| Book Value Per Share | 0.61 X | 1.93 K |
| Cash Flow From Operations | (21.5 M) | 971.22 M |
| Short Ratio | 0.15 X | 4.00 X |
| Earnings Per Share | (1.53) X | 3.12 X |
| Target Price | 6.04 | |
| Number Of Employees | 300 | 18.84 K |
| Beta | -393983.0 | -0.15 |
| Market Capitalization | 84.64 M | 19.03 B |
| Total Asset | 129.13 M | 29.47 B |
| Retained Earnings | (331.45 M) | 9.33 B |
| Working Capital | 18.64 M | 1.48 B |
| Net Asset | 129.13 M |
Note: Purchase by Mvm Partners Llc of 1000000 shares of MDxHealth [view details]
MDxHealth Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MDxHealth . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 22376.4 | |||
| Daily Balance Of Power | 0.85 | |||
| Rate Of Daily Change | 1.1 | |||
| Day Median Price | 1.79 | |||
| Day Typical Price | 1.82 | |||
| Price Action Indicator | 0.17 | |||
| Period Momentum Indicator | 0.17 |
About MDxHealth Buy or Sell Advice
When is the right time to buy or sell MDxHealth SA ADR? Buying financial instruments such as MDxHealth Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having MDxHealth in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Data Storage Thematic Idea Now
Data Storage
Companies making data storages or providing data storage services. The Data Storage theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Data Storage Theme or any other thematic opportunities.
| View All Next | Launch |
Check out MDxHealth Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MDxHealth. If investors know MDxHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 3.099 | Quarterly Revenue Growth 0.205 | Return On Assets (0.11) | Return On Equity (2.41) |
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MDxHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if MDxHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MDxHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.